A phase II study of cabozantinib (cabo) alone or in combination with trastuzumab (T) in patients (pts) with breast cancer brain metastases (BCBM)

被引：0
|
作者：
Leone, Jose Pablo
Hu, Jiani
Barry, William Thomas
Duda, Dan G.
Gerstner, Elizabeth Robins
Jain, Rakesh K.
Tan, Sally
Lawler, Elizabeth S.
Winer, Eric P.
Lin, Nancy U.
Tolaney, Sara M.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.1026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1026
引用
收藏
页数：2
相关论文
共 50 条
  • [21] TRASTUZUMAB (T) AND VINORELBINE (V) FOR PATIENTS (PTS) WITH HER2-OVEREXPRESSING ADVANCED BREAST CANCER (ABC). A PILOT PHASE II STUDY
    Ferrau', Francesco
    Adamo, Vincenzo
    Bordonaro, Roberto
    Caristi, Nicola
    Colina, Paolo
    D'Angelo, Alessandro
    Garipoli, Claudia
    Lavenia, Giuseppe
    Priolo, Domenico
    Rossello, Rosalba
    Tralongo, Paolo
    ANNALS OF ONCOLOGY, 2004, 15 : 25 - 25
  • [22] Phase I/II study of cabozantinib alone or in combination with panitumumab in patients with MET-amplified metastatic colorectal cancer.
    Kawazoe, Akihito
    Ohta, Takashi
    Esaki, Taito
    Kato, Takeshi
    Shinozaki, Eiji
    Taniguchi, Hiroya
    Komatsu, Yoshito
    Fuse, Nozomu
    Wakabayashi, Masashi
    Takakusa, Maiko
    Matsuda, Seiko
    Tamura, Hitomi
    Nomura, Shogo
    Sato, Akihiro
    Fujii, Satoshi
    Nakamura, Yoshiaki
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 146 - 146
  • [23] Phase II trial of patupilone in patients with breast cancer brain metastases
    Peereboom, David
    Brewer, Cathy
    Seidman, Andrew
    NEURO-ONCOLOGY, 2007, 9 (04) : 523 - 523
  • [24] PHASE II TRIAL OF PATUPILONE IN PATIENTS WITH BREAST CANCER BRAIN METASTASES
    Peereboom, D. M.
    Conlin, A. K.
    Seidman, A. D.
    Brewer, C.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1077 - 1077
  • [25] Phase II study of nivolumab (nivo) in combination with relatlimab (rela) in patients (pts) with active melanoma brain metastases (MBM)
    Phillips, Suzanne
    Burton, Elizabeth M.
    Kreidieh, Firas Y.
    Glitza, Isabella Claudia
    McQuade, Jennifer Leigh
    Amaria, Rodabe Navroze
    Diab, Adi
    Patel, Sapna Pradyuman
    Wong, Michael K. K.
    Li, Jing
    Chung, Caroline
    Milton, Denai R.
    Malke, Jared
    Simon, Julie
    Wefel, Jeffrey Scott
    Davies, Michael A.
    Tawbi, Hussein A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] A phase II trial of cabozantinib (Cabo) in patients (pts) with castrate-resistant prostate cancer (CRPC) metastatic to bone (NCT01428219).
    Grivas, Petros
    Daignault, Stephanie
    Cooney, Kathleen A.
    Jacobson, Jon
    Yablon, Corrie
    Ross, Brian Dale
    Chenevert, Thomas L.
    Galban, Craig J.
    Rehemtulla, Alnawaz
    Keller, Evan T.
    Kunju, Priya
    Mehra, Rohit
    Escara-Wilke, June
    Shelley, Greg
    Pienta, Kenneth James
    Hussain, Maha
    Smith, David C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [27] Clinicopathological study of brain metastases in breast cancer patients treated with or without trastuzumab.
    Saito, Y
    Tokuda, Y
    Suzuki, Y
    Umemura, S
    Osamura, RY
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 51S - 51S
  • [28] Trastuzumab deruxtecan in patients with breast cancer with brain metastases: The DE-REAL study
    Botticelli, Andrea
    Fabi, Alessandra
    Rossi, Alessandro
    Caputo, Roberta
    Pisegna, Simona
    Pantano, Francesco
    D'Auria, Giuliana
    Carbognin, Luisa
    Fedele, Palma
    Fabbri, Agnese
    Vernieri, Claudio
    Palleschi, Michela
    Ferretti, Gianluigi
    Paris, Ida
    Di Monte, Elena
    Pavese, Francesco
    Garrone, Ornella
    Giannarelli, Diana
    De laurentiis, Michelino
    Scambia, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Neratinib in combination with trastuzumab for the treatment of advanced breast cancer: A phase I/II study
    Swaby, R.
    Blackwell, K.
    Jiang, Z.
    Sun, Y.
    Dieras, V.
    Zaman, K.
    Zacharchuk, C.
    Powell, C.
    Abbas, R.
    Thakuria, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] Translational Breast Cancer Research Consortium Trial 022: Neratinib and Trastuzumab-Emtansine for HER2+Breast Cancer Brain Metastases (BCBM)
    Freedman, Rachel
    Ren, Siyang
    Tayob, Nabihah
    Gelman, Rebecca
    Smith, Karen L.
    Davis, Raechel
    Pereslete, Alyssa
    Attaya, Victoria
    Cotter, Christine
    Chen, Wendy Y.
    Santa-Maria, Cesar Augusto
    Van Poznak, Catherine
    Moy, Beverly
    Brufsky, Adam M.
    Melisko, Michelle
    O'Sullivan, Ciara C.
    Ashai, Nadia
    Rauf, Yasmeen
    Nangia, Julie
    Trapani, Dario
    Savoie, Jennifer
    Burns, Robyn
    Wolff, Antonio C.
    Winer, Eric
    Rimawi, Mothaffar
    Krop, Ian
    Lin, Nancy U.
    CANCER RESEARCH, 2023, 83 (05)
12345